Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosisResearch in context
Background: Hepatocyte is particularly vulnerable to apoptosis, a hallmark of many liver diseases. Although pro-apoptotic mechanisms have been extensively explored, less is known about the hepatocyte-specific anti-apoptotic molecular events and it lacks effective approach to combat hepatocyte apopto...
Main Authors: | Hong Wang, Chaoliang Ge, Jiyu Zhou, Yitong Guo, Shuang Cui, Ningning Huang, Tingting Yan, Lijuan Cao, Yuan Che, Qiuling Zheng, Xiao Zheng, Frank J. Gonzalez, Guangji Wang, Haiping Hao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-11-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396418304468 |
Similar Items
-
Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis
by: Jiyu Zhou, et al.
Published: (2019-05-01) -
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
by: Jiyu Zhou, et al.
Published: (2020-01-01) -
New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to β-adrenergic stimulation-induced cardiac fibrosisResearch in context
by: Shingo Takahara, et al.
Published: (2019-04-01) -
Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis MiceSummary
by: Pauline T. Ikpa, et al.
Published: (2020-01-01) -
Kanglexin protects against cardiac fibrosis and dysfunction in mice by TGF-β1/ERK1/2 noncanonical pathway
by: Xue Liu, et al.
Published: (2021-01-01)